EUVIMEDEUVIMED entdecken
Systematische Übersicht

Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review

Gregoire B Morand, Alina Diaconescu, Iman Ibrahim, Genevieve Lamarche, Juliana S Ruas, Jacqueline Dalfen, Michael P Hier, Moulay A Alaoui-Jamali, Mariana Maschietto, Sabrina Daniela da Silva iD

Clinical & Experimental Metastasis · 2022-06 · 39 (3) · 407-416

DOI: 10.1007/s10585-022-10148-9 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical & Experimental Metastasis, online erschienen am 27.01.2022. Verfasst von Gregoire B Morand und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, 3755 Côte Ste-Catherine Road, M…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: CIHR, RSBO, NCOHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection with HPV virus and exposure to extrinsic carcinogens are the main causative factors for oropharyngeal squamous cell carcinoma (OPSCC). While HPV-related OPSCC typically shows a better prognosis and may be a candidate for de-intensification therapy, there is a subset of HPV-related cancers that show aggressive phenotype with frequent metastatic spread. The identification and refinement of molecular markers can better serve for prediction of prognosis and thus improve treatment decisions and outcome. We conducted a systematic review according to the PRISMA guidelines of all relevant studies addressing novel biomarkers in publications prior to July 2021. We identified studies that evaluated the association between molecular markers and prognosis in HPV-positive OPSCC. Full-text publications were entirely reviewed, classified, and selected if a clear predictive/prognostic value was seen in patients with HPV-positive OPSCC. Furthermore, a functional analysis of the target genes was conducted to understand biological processes and molecular pathways impacting on HPV-positive OPSCC outcomes. The systematic review yielded a total of 14 studies that matched the inclusion and exclusion criteria. Differential expression was identified for 31 different biomarkers. The first common pattern identified was the association of HPV-related circulating antibodies to activated immune function. Second, gene-gene interaction analysis further identified interacting gene networks tightly implicated in hypoxia tumor metabolism including the Warburg effect. Survival in HPV-positive OPSCC can be predicted by distinct selective biomarkers mainly indicative of immune host response and oxidative metabolism. Among these markers, some were identified to be unsuitable for HPV-positive de-escalation trials aimed at improving patients' quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal NeoplasmsPapillomavirus InfectionsHumansPapillomaviridaePrognosisQuality of LifeSquamous Cell Carcinoma of Head and Neck

Stichwörter der Autor:innen

BiomarkersDe-escalation trialHPV infectionOropharyngeal neoplasms

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, 3755 Côte Ste-Catherine Road, Montreal, QC, H3T 1E2, Canada.
  • Departments of Medicine, Oncology, and Pharmacology and Therapeutics, Faculty of Medicine, Segal Cancer Centre and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill Univers…
  • Department of Structural and Functional Biology, Institute of Biology, Universidade Estadual de Campinas (UNICAMP) and Boldrini Children's Center, Campinas, Sao Paulo, Brazil.
  • Department of Otolaryngology Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, 3755 Côte Ste-Catherine Road, Montreal, QC, H3T 1E2, Canada. sabrina.wurzba@gmail.com.

ORCID-Profile: Sabrina Daniela da Silva

Förderung

  • CIHR
  • RSBO
  • NCOHR

Zitieren

APA

Morand, G. B., Diaconescu, A., Ibrahim, I., Lamarche, G., Ruas, J. S., Dalfen, J., Hier, M. P., Alaoui-Jamali, M. A., Maschietto, M., & da Silva, S. D. (2022). Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review. Clinical & Experimental Metastasis, 39(3), 407-416. https://doi.org/10.1007/s10585-022-10148-9

Vancouver

Morand GB, Diaconescu A, Ibrahim I, Lamarche G, Ruas JS, Dalfen J, et al. Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review. Clinical & Experimental Metastasis. 2022;39(3):407-416. doi:10.1007/s10585-022-10148-9

BibTeX
@article{Morand2022,
  author = {Morand, Gregoire B and Diaconescu, Alina and Ibrahim, Iman and Lamarche, Genevieve and Ruas, Juliana S and Dalfen, Jacqueline and Hier, Michael P and Alaoui-Jamali, Moulay A and Maschietto, Mariana and da Silva, Sabrina Daniela},
  title = {Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review},
  journal = {Clinical & Experimental Metastasis},
  year = {2022},
  volume = {39},
  number = {3},
  pages = {407--416},
  doi = {10.1007/s10585-022-10148-9}
}
Kostenlos starten →